Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CVP, JAPAC

Global President TAVR & Surg

CVP, TMTT

SVP, Corporate Controller

CVP, EMEACLA and JAPAC

CVP,Strategy/Corp Development

CVP, Critical Care

CVP, Chief Financial Officer

GM & SVP, Surgical

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitorin...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CVP, JAPAC
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, JAPAC
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	Global President TAVR & Surg
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, TMTT
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Corporate Controller
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, JAPAC
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CEO
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, EMEACLA and JAPAC
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP,Strategy/Corp Development
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, Critical Care
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CVP,Strategy/Corp Development
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CVP, Critical Care
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CVP, Chief Financial Officer
2024-05-07	Premium	acquired	Premium	Premium	Premium	CVP, Chief Financial Officer
2024-05-07	Premium	sold (taxes)	Premium	Premium	Premium	CVP, TMTT
2024-05-07	Premium	sold	Premium	Premium	Premium	CVP, JAPAC
2024-05-07	Premium	acquired	Premium	Premium	Premium	Global President TAVR & Surg
2024-05-07	Premium	acquired	Premium	Premium	Premium	CEO

EW - Edwards Lifesciences Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for EW